Triptolide sensitizes cancer cells to nucleoside DNA methyltransferase inhibitors through inhibition of DCTPP1-mediated cell-intrinsic resistance
Jianyong Liu(Academe of Grassland And Animal Science), Srinivasan Yegnasubramanian(Johns Hopkins University), Joong Sup Shim(University of Macau), Michelle A. Rudek(Dana-Farber Cancer Institute), Jun O. Liu(Central China Normal University), Glenn Hauk(Johns Hopkins University), Jonathan B. Coulter(Johns Hopkins University), William G. Nelson(Johns Hopkins University), David Esopi(AstraZeneca (United States)), Ruchama C. Steinberg(Johns Hopkins University), Ajay Vaghasia(Sidney Kimmel Comprehensive Cancer Center), Hugh Giovinazzo(Sidney Kimmel Comprehensive Cancer Center), James M. Berger(Johns Hopkins University), Teresia Wanjiku(Johns Hopkins University), Nicole Castagna(Johns Hopkins University), Jianying Zhou(First Affiliated Hospital Zhejiang University), Minh‐Tam Pham(Johns Hopkins University), Qingli He(Chinese Academy of Sciences), Kunhwa Kim(The University of Texas MD Anderson Cancer Center), Roshan Chikarmane(Johns Hopkins University), Archana Rachakonda(Johns Hopkins University), Rulin Wang(Sidney Kimmel Comprehensive Cancer Center), Nicole M. Anders(Johns Hopkins University), Philipp Nuhn(Ludwig-Maximilians-Universität München), Jianya Zhou(First Affiliated Hospital Zhejiang University)
Cited by 5
Related Papers
Transcriptional programs of neoantigen-specific TIL in anti-PD-1-treated lung cancers
|Nature|2021|546
Camrelizumab plus carboplatin and pemetrexed versus chemotherapy alone in chemotherapy-naive patients with advanced non-squamous non-small-cell lung cancer (CameL): a randomised, open-label, multicentre, phase 3 trial
|The Lancet Respiratory Medicine|2020|504
Treatment and prevention of intraepithelial neoplasia: an important target for accelerated new agent development.
|PubMed|2002|383
Eukaryotic Initiation Factor 2α-independent Pathway of Stress Granule Induction by the Natural Product Pateamine A
|Journal of Biological Chemistry|2006|265